Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

• Main Authors: M. Gattinara (Author), E. Valcamonica (Author), A. Salmaso (Author), B. Teruzzi (Author), A. Lurati (Author), I. Pontikaki (Author), V. Gerloni (Author), G. De Marco (Author), F. Fantini (Author)
• Format: Book
• Published: PAGEPress Publications, 2011-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: To evaluate, in long-term open label prospective study, infliximab as therapeutic choice for Juvenile Idiopathic Arthritis (JIA) non responsive to conventional therapy. Methods: We enrolled to treat with infliximab 78 JIA patients (66 females, 12 males): the mean age was 20.7±7.1 years (...